MedTrace Logo

A Study Comparing Two Topicals in the Treatment of Acne Vulgaris

NCT03743038 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2021-04-06

Study results available
· View outcomes & findings →

Summary

A Randomized, Evaluator-Blinded, Bilateral Comparison Study to Evaluate the Safety and Efficacy of Two Topicals in the Treatment of Subjects With Acne Vulgaris (Study FX2018-23).

Conditions

  • Acne Vulgaris

Interventions

DRUG

FMX101 vehicle

FMX101 vehicle - hydrophobic oil based vehicle (Test Article A)

OTHER

Hydro-alcohol solution

Hydro-alcohol solution based vehicle (Test Article B)

Sponsors & Collaborators

  • Vyne Therapeutics Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2019-02-11
Completion
2019-02-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743038 on ClinicalTrials.gov